NCT03325322View on ClinicalTrials.gov

Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

PHASE2SuspendedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Chronic Kidney DiseasesDiabetes MellitusDiabetic Nephropathies

Interventions

DIETARY_SUPPLEMENT

Fisetin

Flavonoid family

DRUG

Placebo oral capsule

Placebo

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER